Zimmer Biomet Chairman, President and CEO Ivan Tornos Joins OREF Board of Trustees
ROSEMONT, Ill., May 29, 2025 /PRNewswire/ -- The Orthopaedic Research and Education Foundation (OREF), the leading private nonprofit organization funding musculoskeletal (MSK) research across all orthopaedic sub-specialties, is pleased to announce that Ivan Tornos, Chairman, President and CEO of orthopaedic medical device company Zimmer Biomet has joined its Board of Trustees.
Mr. Tornos joined Zimmer Biomet in 2018 as Group President, Orthopedics. Prior to his appointment as President and Chief Executive Officer in 2023, he held the positions of Group President, Global Businesses and the Americas, and Chief Operating Officer with responsibility for overseeing all global businesses at Zimmer Biomet. He was elected Chairman of the Board of Directors of Zimmer Biomet, a global leader in musculoskeletal health, in May of 2025.
OREF Board President, Joshua J. Jacobs, MD, stated, "On behalf of the entire board, I am delighted to welcome Ivan to OREF. Our two organizations have a long history of collaboration and a shared commitment to improving patient care and outcomes. Ivan's presence on the OREF board will bring heightened visibility to our mission and to the need for more research funding. His service to OREF and the financial support of Zimmer Biomet underscore his commitment to improving the health of our communities here in the U.S. and throughout the world."
"I am thrilled to be joining the OREF board. Now more than ever, it's important we move with a sense of urgency and deep purpose to ensure that musculoskeletal research advances at a much faster pace and delivers even bolder solutions. There are countless patients currently waiting on the sidelines who could benefit from the meaningful work that we will do together, and I'm committed to doing all I can to reduce the current gaps in this area," said Ivan Tornos.
The growing burden of MSK conditions in the United States is well documented with MSK-related diseases and injuries affecting more than half of the adult population and imposing an estimated economic burden of $980 billion annually.1 Despite the outsized impact of MSK diseases on quality of life and the U.S. economy, funding for MSK conditions is disproportionately low when comparing the physical and economic burden of various diseases. OREF is a leading voice in advocating for increased MSK research funding and strongly believes that the nation's healthcare will not improve unless and until MSK research funding becomes a national priority.
OREF grantees' success in securing additional funding from the NIH and other government entities is unparalleled within the MSK research community. Research published in JBJS demonstrates that OREF grant recipients are more likely to receive subsequent NIH funding compared to other applicants (23.5 percent vs. 20.6 percent), with Career Development Grant recipients achieving a 48.4 percent success rate.2 Given the limited availability of MSK research funds, investing in a reputable independent source with a proven return on investment is essential. OREF's collaboration with more than 60 MSK-related organizations is a key factor in its success in funding significant and impactful research that improves clinical practice and patient outcomes.
About OREF
An independent 501(c)3 nonprofit, OREF strives to improve clinical care and patient outcomes by advancing innovative research, developing new investigators, and uniting the orthopaedic community in promoting musculoskeletal health. The Foundation raises funds to support research on diseases and injuries of bones, nerves, muscles, and tendons and to enhance clinical care leading to improved health, increased activity, and a better quality of life for patients. For more information, visit oref.org or follow OREF on X and LinkedIn.
1United States Bone and Joint Initiative: The Burden of Musculoskeletal Diseases in the United States (BMUS), Third Edition, 2014. Rosemont, IL. Available at https://bmus.latticegroup.com/fourth-edition/if0/healthcare-utilization-and-economic-cost
2Li, Alan K. BS1,a; Kendal, Joseph K. MD, MSc2; Hamad, Christopher D. MD2; Peterson, Nicholas V. MD2; Asachi, Parsa BA1; Taylor, Jeremiah M. BS1; Le, Michael M. MD1; Lloyd, Trevor S. BS1; Wessel, Lauren E. MD2; Bernthal, Nicholas M. MD2. Identifying Predictors of Successful Conversion from OREF Grants to Extramural Federal Funding Among Orthopaedic Surgeons. The Journal of Bone and Joint Surgery 107(1):p 96-103, January 1, 2025. DOI: 10.2106/JBJS.24.0064
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-chairman-president-and-ceo-ivan-tornos-joins-oref-board-of-trustees-302466210.html
SOURCE Orthopaedic Research and Education Foundation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 hours ago
- Yahoo
What your blood quietly reveals about your eating habits
Blood and urine tests have been found to detect the amount of ultraprocessed foods (UPFs) a person eats, according to new research. Using machine learning, scientists at the National Institutes of Health (NIH) identified hundreds of metabolites (molecules produced during metabolism) that correlated with processed food intake. The team developed a "biomarker score" that predicts ultraprocessed food intake based on metabolite measurements in blood and urine, according to Erikka Loftfield, Ph.D., M.P.H., of the National Cancer Institute in Maryland. Premature Death Linked To Certain Type Of Food, Study Reveals The researchers drew baseline data from 718 older adults who provided urine and blood samples and reported their dietary habits over a 12-month period, as detailed in an NIH press release. Next, they conducted a small clinical trial of 20 adults. For two weeks, the group ate a diet high in ultraprocessed foods, and for another two weeks they ate a diet with no UPFs. Read On The Fox News App "In our study, we found that hundreds of serum and urine metabolites were correlated with percentage energy from ultraprocessed food intake," Loftfield told Fox News Digital. The findings were published in the journal PLOS Medicine. The Worst Foods To Buy In The Supermarket And The Better Choices Instead Large-scale studies investigating the health risks of ultraprocessed foods often rely on self-reported dietary questionnaires, which can be prone to errors, per the NIH. The new blood and urine test helps to reduce human error by using objective biomarkers, a growing area of interest among researchers. Loftfield added, "It was surprising to find that UPF-correlated metabolites are involved in numerous and diverse biological pathways, underscoring the complex impact of diet on the metabolome." Ultraprocessed foods are defined as "ready-to-eat or ready-to-heat, industrially manufactured products, typically high in calories and low in essential nutrients," according to the NIH. Click Here To Sign Up For Our Health Newsletter Chronic diseases, obesity and various forms of cancer have been linked to diets that are heavy in UPFs. Despite promising results, the researchers emphasized that the new method will require further validation before broader use. Since the current trial focused mainly on older adults, more research is needed across various age groups and diets, the experts said. "Metabolite scores should be evaluated and improved in populations with different diets and a wide range of UPF intake," Loftfield acknowledged. This method could potentially be used in future research to link the consumption of processed foods with chronic diseases, according to the researchers. For more Health articles, visit "For individuals concerned about ultraprocessed food intake, one practical recommendation is to use 'nutrition facts' labels to avoid foods high in added sugars, saturated fat and sodium, as this can limit UPF intake and align with robust scientific research on diet and health," Loftfield article source: What your blood quietly reveals about your eating habits
Yahoo
a day ago
- Yahoo
Trump Admin Sets HIV Research Back ‘A Decade' With Massive Funding Cut
In 2019, President Donald Trump launched an ambitious new health program with a singular aim: reduce HIV transmission in America by 90 percent. Six years and a change of president later, in his new administration, Trump appears to have all but given up on that idea. On Friday, research programs at Duke University and the Scripps Research Institute that are working to deliver an HIV vaccine were told by the National Institutes of Health (NIH) that their $258 million funding would be stopped. The vaccine manufacturer Moderna said that its clinical trials, funded by the NIH, have also been paused. 'The consortia for HIV/AIDS vaccine development and immunology was reviewed by NIH leadership, which does not support it moving forward,' a senior official at the agency told The New York Times. 'NIH expects to be shifting its focus toward using currently available approaches to eliminate HIV/AIDS,' they added. The news comes at 'a terrible time' for HIV vaccine research, an immunology professor at Scripps told CBS News. 'This is a decision with consequences that will linger. This is a setback of probably a decade for HIV vaccine research.' This is just the latest round of funding cuts to HIV research, part of a vast swath of grant terminations undertaken by the NIH. Forty percent of the health bodies' $47 billion budget is expected to be cut by Republican lawmakers, with 20,000 jobs on the chopping block as HHS secretary Robert F. Kennedy Jr. pledges to shrink the size of the government and 'make America healthy again.' More than 230 of the nearly 800 research grants that have so far been cut were HIV and AIDS-specific. The impact of the cuts is expected to be global. While HIV infections have been on the decline since 2010, in 2023, there were 1.3 million new cases around the world, with 120,000 of those in children, the World Health Organization reports. 'The HIV pandemic will never be ended without a vaccine, so killing research on one will end up killing people,' John Moore, an HIV researcher at Weill Cornell Medicine in New York, told The New York Times. 'The NIH's multiyear investment in advanced vaccine technologies shouldn't be abandoned on a whim like this,' he said. A spokesperson for the HHS defended the cuts to CBS News, saying the 'complex and duplicative health programs have resulted in serious duplication of efforts' and that '27 separate programs that address HIV/AIDS' have spent $7.5 billion. Critical HIV/AIDS programs 'will continue,' the spokesperson said, under the proposed Administration for a Healthy America. Still, with current research on ice, experts are saying that the ongoing (and expected-to-continue) cuts to this necessary research have 'destroyed with an email in a day' what the research community has spent 25 years building.
Fox News
a day ago
- Fox News
What your blood quietly reveals about your eating habits
Blood and urine tests have been found to detect the amount of ultraprocessed foods (UPFs) a person eats, according to new research. Using machine learning, scientists at the National Institutes of Health (NIH) identified hundreds of metabolites (molecules produced during metabolism) that correlated with processed food intake. The team developed a "biomarker score" that predicts ultraprocessed food intake based on metabolite measurements in blood and urine, according to Erikka Loftfield, Ph.D., M.P.H., of the National Cancer Institute in Maryland. The researchers drew baseline data from 718 older adults who provided urine and blood samples and reported their dietary habits over a 12-month period, as detailed in an NIH press release. Next, they conducted a small clinical trial of 20 adults. For two weeks, the group ate a diet high in ultraprocessed foods, and for another two weeks they ate a diet with no UPFs. "In our study, we found that hundreds of serum and urine metabolites were correlated with percentage energy from ultraprocessed food intake," Loftfield told Fox News Digital. The findings were published in the journal PLOS Medicine. Large-scale studies investigating the health risks of ultraprocessed foods often rely on self-reported dietary questionnaires, which can be prone to errors, per the NIH. The new blood and urine test helps to reduce human error by using objective biomarkers, a growing area of interest among researchers. Loftfield added, "It was surprising to find that UPF-correlated metabolites are involved in numerous and diverse biological pathways, underscoring the complex impact of diet on the metabolome." Ultraprocessed foods are defined as "ready-to-eat or ready-to-heat, industrially manufactured products, typically high in calories and low in essential nutrients," according to the NIH. Chronic diseases, obesity and various forms of cancer have been linked to diets that are heavy in UPFs. Despite promising results, the researchers emphasized that the new method will require further validation before broader use. Since the current trial focused mainly on older adults, more research is needed across various age groups and diets, the experts said. "Metabolite scores should be evaluated and improved in populations with different diets and a wide range of UPF intake," Loftfield acknowledged. This method could potentially be used in future research to link the consumption of processed foods with chronic diseases, according to the researchers. For more Health articles, visit "For individuals concerned about ultraprocessed food intake, one practical recommendation is to use 'nutrition facts' labels to avoid foods high in added sugars, saturated fat and sodium, as this can limit UPF intake and align with robust scientific research on diet and health," Loftfield suggested.
